Source comparison
TB-4 Peptide: Dosage Protocols and Half-Life Comparison
Research protocols vary based on injury type, species, and study duration. This table summarizes standard TB-4 peptide dosing across published studies. Dermal wound healing (rodent) 6–12 mg/kg/day Subcutaneous (peri-wound) 7–14 days Time to complete re-epithel
This comparison does not assign a generated winner or score.
- Research protocols vary based on injury type, species, and study duration. This table summarizes standard TB-4 peptide dosing across published studies.
- Dermal wound healing (rodent)
- 6–12 mg/kg/day
- Subcutaneous (peri-wound)
- 7–14 days
- Time to complete re-epithelialization
- Accelerated closure by 40–60% vs control; reduced scar width
- Myocardial infarction (large animal)
- 0.5–2 mg/kg twice weekly
- Intravenous or intramyocardial
- 28 days
- Ejection fraction preservation
- 15–20% greater LVEF retention; reduced infarct size
- Corneal injury (rabbit)
- Topical 0.1% solution
- Ophthalmic drops, 4× daily
- 7–10 days
- Corneal opacity and re-epithelialization
- Complete healing 7 days earlier; minimal neovascularization
- Tendon repair (rodent)
- 10 mg/kg every other day
- Subcutaneous (peri-tendon)
- 14–21 days
- Tensile strength and collagen alignment
- 25–35% increase in breaking strength; improved fiber alignment